ZEPP HEALTH CORP Research and Development Expense
ZEPP HEALTH CORP (ZEPP) reported Research and Development Expense of $45.32 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-24
CNY
| Period end | Research and Development Expense 12 month |
|---|---|
| 2023-12-31 | 361.81M CNY 20-F · filed 2024-04-23 |
| 2022-12-31 | 517.12M CNY 20-F · filed 2024-04-23 |
| 2021-12-31 | 515.08M CNY 20-F · filed 2024-04-23 |
| 2020-12-31 | 538.01M CNY 20-F · filed 2023-04-24 |
| 2019-12-31 | 430.82M CNY 20-F · filed 2022-04-28 |
| 2018-12-31 | 263.22M CNY 20-F · filed 2021-04-19 |
| 2017-12-31 | 153.83M CNY 20-F · filed 2020-04-23 |
| 2016-12-31 | 132.30M CNY 20-F · filed 2019-04-12 |
| 2015-12-31 | 61.55M CNY 20-F · filed 2018-04-27 |
USD
| Period end | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $45.32M 20-F · filed 2026-04-24 | |
| 2024-12-31 | $46.16M 20-F · filed 2026-04-24 | |
| 2023-12-31 | $51.50M 20-F · filed 2026-04-24 | $50.96M 20-F · filed 2024-04-23 |
| 2022-12-31 | $77.30M 20-F · filed 2025-04-25 | $74.98M 20-F · filed 2023-04-24 |
| 2021-12-31 | $80.83M 20-F · filed 2022-04-28 | |
| 2020-12-31 | $82.45M 20-F · filed 2021-04-19 | |
| 2019-12-31 | $61.88M 20-F · filed 2020-04-23 | |
| 2018-12-31 | $38.28M 20-F · filed 2019-04-12 | |
| 2017-12-31 | $23.64M 20-F · filed 2018-04-27 |